sanofi (SAN:EN Paris)
Last €80.79 EUR
Change Today -0.76 / -0.93%
Volume 2.2M
As of 11:35 AM 06/19/13 All times are local (Market data is delayed by at least 15 minutes).
Financial Statements for sanofi (SAN)
Year over year, Sanofi has been seen their bottom line shrink from €5.7B EUR to €5.0B EUR despite an increase in revenues from €33.4B EUR to €34.9B EUR. An increase in the percentage of sales devoted to income tax expenses from 1.36% to 3.24% was a key component in the falling bottom line in the face of rising revenues.
View Income Statement In U.S. Dollar| Currency in Millions of Euros | As of: | Dec 31 2009 Restated EUR | Dec 31 2010 Restated EUR | Dec 31 2011 Restated EUR | Dec 31 2012 EUR | 4 Year Trend |
| Revenues | 29,785.0 | 32,367.0 | 33,389.0 | 34,947.0 |  | |
| TOTAL REVENUES | 31,232.0 | 34,036.0 | 35,058.0 | 35,957.0 | | |
| Cost of Goods Sold | 8,017.0 | 9,256.0 | 10,426.0 | 11,095.0 | | |
| GROSS PROFIT | 23,215.0 | 24,780.0 | 24,632.0 | 24,862.0 | | |
| Selling General & Admin Expenses, Total | 7,464.0 | 8,149.0 | 8,536.0 | 8,947.0 | | |
| R&D Expenses | 4,626.0 | 4,547.0 | 4,811.0 | 4,922.0 | | |
| Depreciation & Amortization, Total | 3,528.0 | 3,529.0 | 3,314.0 | 3,291.0 | | |
| Other Operating Expenses | -340.0 | -80.0 | 235.0 | -258.0 | | |
| OTHER OPERATING EXPENSES, TOTAL | 15,278.0 | 16,145.0 | 16,896.0 | 16,902.0 | | |
| OPERATING INCOME | 7,937.0 | 8,635.0 | 7,736.0 | 7,960.0 | | |
| Interest Expense | -310.0 | -385.0 | -425.0 | -417.0 | | |
| Interest and Investment Income | 88.0 | 61.0 | 100.0 | 68.0 | | |
| Other Non-Operating Expenses, Total | 917.0 | 799.0 | 1,027.0 | 247.0 | | |
| Other Non-Operating Income (Expenses) | -9.0 | -18.0 | -48.0 | -88.0 | | |
| Merger & Restructuring Charges | -1,170.0 | -1,526.0 | -1,855.0 | -1,164.0 | | |
| Gain (Loss) on Sale of Investments | -- | -- | -49.0 | -6.0 | | |
| Gain (Loss) on Sale of Assets | -- | -- | -18.0 | -- | | |
| Other Unusual Items, Total | -372.0 | -433.0 | -127.0 | -418.0 | | |
| EBT, INCLUDING UNUSUAL ITEMS | 7,090.0 | 7,151.0 | 6,389.0 | 6,270.0 | | |
| Income Tax Expense | 1,399.0 | 1,430.0 | 455.0 | 1,134.0 | | |
| Minority Interest in Earnings | -426.0 | -254.0 | -241.0 | -169.0 | | |
| Earnings from Continuing Operations | 5,691.0 | 5,721.0 | 5,934.0 | 5,136.0 | | |
| NET INCOME | 5,265.0 | 5,467.0 | 5,693.0 | 4,967.0 | | |
| NET INCOME TO COMMON INCLUDING EXTRA ITEMS | 5,265.0 | 5,467.0 | 5,693.0 | 4,967.0 | | |
| NET INCOME TO COMMON EXCLUDING EXTRA ITEMS | 5,265.0 | 5,467.0 | 5,693.0 | 4,967.0 | | |
| Recently Viewed | |||
| SAN:FP | €80.79 EUR | -0.76 |  |
| Company | Last | Change |
| Bayer AG | €84.20 EUR | +0.31 |
| GlaxoSmithKline PLC | 1,665 GBp | -11.00 |
| Merck & Co Inc | $47.74 USD | -0.01 |
| Novartis AG | SFr.67.15 CHF | 0.00 |
| Roche Holding AG | SFr.230.40 CHF | +1.50 |
| View Industry Companies | ||
Industry Analysis
SAN
Industry Average
| Valuation | SAN | Industry Range |
| Price/Earnings | 27.2x |
|
| Price/Sales | 3.2x |
|
| Price/Book | 2.0x |
|
| Price/Cash Flow | 15.3x |
|
| TEV/Sales | 2.6x |
|
Post a JobJobs
- Chicago, IL | DunnhumbyusaPosted: Jun 18
- Thomasville, GA | Flowers FoodsPosted: Jun 07
- San Francisco, CA | YelpPosted: Jun 06
- San Francisco, CA | PeoplematterPosted: Jun 06
